Boothbay Fund Management’s Healthcare Services Acquisition Corporation Class A Common Stock HCAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-197,878
Closed -$1.97M 2676
2022
Q3
$1.97M Buy
197,878
+97,614
+97% +$966K 0.05% 582
2022
Q2
$987K Buy
100,264
+264
+0.3% +$2.6K 0.03% 815
2022
Q1
$980K Sell
100,000
-9,821
-9% -$95.9K 0.02% 915
2021
Q4
$1.07M Sell
109,821
-26,882
-20% -$263K 0.03% 716
2021
Q3
$1.33M Buy
136,703
+993
+0.7% +$9.61K 0.04% 624
2021
Q2
$1.31M Buy
135,710
+1,564
+1% +$15.2K 0.04% 565
2021
Q1
$1.3M Buy
+134,146
New +$1.34M 0.05% 490

Boothbay Fund Management's HCAR Position: Q4 2022 in Review

Boothbay Fund Management sold out of Healthcare Services Acquisition Corporation Class A Common Stock (HCAR) in Q4 2022, closing a stake of 197,878 shares — an estimated $1.97M sold.

Boothbay Fund Management first reported a position in HCAR in Q1 2021 and held it in 7 quarters. The position peaked at $1.97M in Q3 2022. 0 funds tracked by Wall St. Rank hold HCAR as of Q4 2022.

  • Boothbay Fund Management reported no remaining Healthcare Services Acquisition Corporation Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Boothbay Fund Management sold 197,878 Healthcare Services Acquisition Corporation Class A Common Stock shares in Q4 2022, an estimated $1.97M.
  • Boothbay Fund Management first reported a position in Healthcare Services Acquisition Corporation Class A Common Stock in Q1 2021 and held it in 7 quarters.
  • Boothbay Fund Management's Healthcare Services Acquisition Corporation Class A Common Stock position peaked at $1.97M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Class A Common Stock as of Q4 2022.

Based on Boothbay Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.